Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1974 2
1975 1
1976 1
1989 1
1990 1
1992 6
1993 1
1994 1
1996 1
1997 3
1999 2
2000 1
2001 1
2002 1
2003 3
2004 7
2005 1
2006 3
2007 5
2008 3
2009 7
2010 7
2011 5
2012 9
2013 16
2014 7
2015 17
2016 8
2017 5
2018 7
2019 8
2020 5
2021 4
2022 2
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

140 results

Results by year

Filters applied: . Clear all
Page 1
HLA-DP on Epithelial Cells Enables Tissue Damage by NKp44+ Natural Killer Cells in Ulcerative Colitis.
Baumdick ME, Niehrs A, Degenhardt F, Schwerk M, Hinrichs O, Jordan-Paiz A, Padoan B, Wegner LHM, Schloer S, Zecher BF, Malsy J, Joshi VR, Illig C, Schröder-Schwarz J, Möller KJ; Hamburg Intestinal Tissue Study Group; Martin MP, Yuki Y, Ozawa M, Sauter J, Schmidt AH, Perez D, Giannou AD, Carrington M, Davis RS, Schumacher U, Sauter G, Huber S, Puelles VG, Melling N, Franke A; International Inflammatory Bowel Disease Genetics Consortium; Altfeld M, Bunders MJ. Baumdick ME, et al. Gastroenterology. 2023 Oct;165(4):946-962.e13. doi: 10.1053/j.gastro.2023.06.034. Epub 2023 Jul 15. Gastroenterology. 2023. PMID: 37454979 Free article.
Genetic coding variant in complement factor B (CFB) is associated with increased risk for perianal Crohn's disease and leads to impaired CFB cleavage and phagocytosis.
Akhlaghpour M, Haritunians T, More SK, Thomas LS, Stamps DT, Dube S, Li D, Yang S, Landers CJ, Mengesha E, Hamade H, Murali R, Potdar AA, Wolf AJ, Botwin GJ, Khrom M; International IBD Genetics Consortium; Ananthakrishnan AN, Faubion WA, Jabri B, Lira SA, Newberry RD, Sandler RS, Sartor RB, Xavier RJ, Brant SR, Cho JH, Duerr RH, Lazarev MG, Rioux JD, Schumm LP, Silverberg MS, Zaghiyan K, Fleshner P, Melmed GY, Vasiliauskas EA, Ha C, Rabizadeh S, Syal G, Bonthala NN, Ziring DA, Targan SR, Long MD, McGovern DPB, Michelsen KS. Akhlaghpour M, et al. Gut. 2023 Nov;72(11):2068-2080. doi: 10.1136/gutjnl-2023-329689. Epub 2023 Apr 20. Gut. 2023. PMID: 37080587 Free article.
A retrospective cohort study: pre-operative oral enteral nutritional optimisation for Crohn's disease in a UK tertiary IBD centre.
Meade S, Patel KV, Luber RP, O'Hanlon D, Caracostea A, Pavlidis P, Honap S, Anandarajah C, Griffin N, Zeki S, Ray S, Mawdsley J, Samaan MA, Anderson SH, Darakhshan A, Adams K, Williams A, Sanderson JD, Lomer M, Irving PM. Meade S, et al. Among authors: sanderson jd. Aliment Pharmacol Ther. 2022 Aug;56(4):646-663. doi: 10.1111/apt.17055. Epub 2022 Jun 20. Aliment Pharmacol Ther. 2022. PMID: 35723622 Free PMC article.
Correction to: Efficacy, safety and drug survival of thioguanine as maintenance treatment for inflammatory bowel disease: a retrospective multi-centre study in the United Kingdom.
Bayoumy AB, van Liere ELSA, Simsek M, Warner B, Loganayagam A, Sanderson JD, Anderson S, Nolan J, de Boer NK, Mulder CJJ, Ansari A. Bayoumy AB, et al. Among authors: sanderson jd. BMC Gastroenterol. 2022 Apr 26;22(1):208. doi: 10.1186/s12876-021-01992-2. BMC Gastroenterol. 2022. PMID: 35473670 Free PMC article. No abstract available.
An observational study of switching infliximab biosimilar: no adverse impact on inflammatory bowel disease control or drug levels with first or second switch.
Luber RP, O'Neill R, Singh S, Sharma E, Cunningham G, Honap S, Meade S, Ray S, Anderson SH, Mawdsley J, Sanderson JD, Samaan MA, Arkir Z, Irving PM. Luber RP, et al. Among authors: sanderson jd. Aliment Pharmacol Ther. 2021 Sep;54(5):678-688. doi: 10.1111/apt.16497. Epub 2021 Jul 5. Aliment Pharmacol Ther. 2021. PMID: 34223654
Human marginal zone B cell development from early T2 progenitors.
Tull TJ, Pitcher MJ, Guesdon W, Siu JHY, Lebrero-Fernández C, Zhao Y, Petrov N, Heck S, Ellis R, Dhami P, Kadolsky UD, Kleeman M, Kamra Y, Fear DJ, John S, Jassem W, Groves RW, Sanderson JD, Robson MG, D'Cruz DP, Bemark M, Spencer J. Tull TJ, et al. Among authors: sanderson jd. J Exp Med. 2021 Apr 5;218(4):e20202001. doi: 10.1084/jem.20202001. J Exp Med. 2021. PMID: 33538776 Free PMC article.
Reply.
Prescott NJ, Taylor KM, Sanderson JD. Prescott NJ, et al. Among authors: sanderson jd. Clin Gastroenterol Hepatol. 2021 Apr;19(4):858. doi: 10.1016/j.cgh.2020.06.020. Epub 2020 Nov 26. Clin Gastroenterol Hepatol. 2021. PMID: 33249020 No abstract available.
Efficacy, safety and drug survival of thioguanine as maintenance treatment for inflammatory bowel disease: a retrospective multi-centre study in the United Kingdom.
Bayoumy AB, van Liere ELSA, Simsek M, Warner B, Loganayagam A, Sanderson JD, Anderson S, Nolan J, de Boer NK, Mulder CJJ, Ansari A. Bayoumy AB, et al. Among authors: sanderson jd. BMC Gastroenterol. 2020 Sep 11;20(1):296. doi: 10.1186/s12876-020-01441-6. BMC Gastroenterol. 2020. PMID: 32917155 Free PMC article.
140 results